Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation

References

• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Ercan G, Karlitepe A, Ozpolat B. Pancreatic cancer stem cells and therapeutic approaches. Anticancer Res. 2017;37:2761–2775.
   PubMed Web of Science ®Google Scholar
• Raj D, Aicher A, Heeschen C. Concise review: stem cells in pancreatic cancer: from concept to translation. Stem Cells. 2015;33:2893–2902.
   PubMed Web of Science ®Google Scholar
• Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030–1037.
   PubMed Web of Science ®Google Scholar
• Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313–323.
   PubMed Web of Science ®Google Scholar
• Li C, Wu JJ, Hynes M, et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. Gastroenterology. 2011;141(6):2218–2227.e5.
   Web of Science ®Google Scholar
• Kim MP, Fleming JB, Wang H, et al. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PloS One. 2011;6:e20636.
   PubMed Web of Science ®Google Scholar
• Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells–perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344.
   PubMedGoogle Scholar
• Liu Y, Nenutil R, Appleyard MV, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014;110:2063–2071.
   PubMedGoogle Scholar
• Efroni S, Duttagupta R, Cheng J, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–447.
   PubMed Web of Science ®Google Scholar
• Zaidan NZ, Walker KJ, Brown JE, et al. Compartmentalization of HP1 proteins in pluripotency acquisition and maintenance. Stem Cell Rep. 2018;10:627–641.
   PubMed Web of Science ®Google Scholar
• Kidder BL, He R, Wangsa D, et al. SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation. Cancer Res. 2017;77:6729–6745.
   PubMed Web of Science ®Google Scholar
• Christogianni A, Chatzantonaki E, Soupsana K, et al. Heterochromatin remodeling in embryonic stem cells proceeds through stochastic de-stabilization of regional steady-states. Biochim Biophys Acta. 2017;1860:661–673.
   PubMedGoogle Scholar
• Hiratani I, Ryba T, Itoh M, et al. Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome Res. 2010;20:155–169.
   PubMed Web of Science ®Google Scholar
• Fussner E, Djuric U, Strauss M, et al. Constitutive heterochromatin reorganization during somatic cell reprogramming. EMBO J. 2011;30:1778–1789.
   PubMed Web of Science ®Google Scholar
• Ning X, Du Y, Ben Q, et al. Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs. Cell Cycle (Georgetown, Tex). 2016;15:403–412.
   PubMed Web of Science ®Google Scholar
• Platet N, Mayol JF, Berger F, et al. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett. 2007;581:1435–1440.
   PubMed Web of Science ®Google Scholar
• Mitsutake N, Iwao A, Nagai K, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007;148:1797–1803.
   PubMed Web of Science ®Google Scholar
• Silva J, Barrandon O, Nichols J, et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008;6:e253.
   PubMed Web of Science ®Google Scholar
• Marchion DC, Bicaku E, Daud AI, et al. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res. 2005;65:3815–3822.
   PubMed Web of Science ®Google Scholar
• Tay Y, Zhang J, Thomson AM, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455:1124–1128.
   PubMed Web of Science ®Google Scholar
• Sergeant G, Vankelecom H, Gremeaux L, et al. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat Reviews Clin Oncology. 2009;6:580–586.
   PubMed Web of Science ®Google Scholar
• Bhagwandin VJ, Bishop JM, Wright WE, et al. The metastatic potential and chemoresistance of human pancreatic cancer stem cells. PloS One. 2016;11:e0148807.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang CY, Liu T, et al. Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J Gastroenterol. 2008;14:925–930.
   PubMed Web of Science ®Google Scholar
• Gaviraghi M, Tunici P, Valensin S, et al. Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Biosci Rep. 2011;31:45–55.
   PubMed Web of Science ®Google Scholar
• Nieto MA. Epithelial plasticity: a common theme in embryonic and cancer cells. Science (New York, NY). 2013;342:1234850.
   Google Scholar
• Liu S, Cong Y, Wang D, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2014;2:78–91.
   PubMed Web of Science ®Google Scholar
• Cabrera MC, Hollingsworth RE, Hurt EM. Cancer stem cell plasticity and tumor hierarchy. World J Stem Cells. 2015;7:27–36.
   PubMed Web of Science ®Google Scholar
• Wang W, Quan Y, Fu Q, et al. Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts. PloS One. 2014;9:e84654.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Sancho P. More challenges ahead-metabolic heterogeneity of pancreatic cancer stem cells. Mol Cell Oncol. 2016;3:e1105353.
   PubMed Web of Science ®Google Scholar
• Sancho P, Alcala S, Usachov V, et al. The ever-changing landscape of pancreatic cancer stem cells. Pancreatology. 2016;16:489–496.
   PubMed Web of Science ®Google Scholar